Literature DB >> 33242814

The COVID-19 pandemic and its impact on substance use: Implications for prevention and treatment.

Felipe Ornell1, Helena Ferreira Moura2, Juliana Nichterwitz Scherer3, Flavio Pechansky2, Felix Henrique Paim Kessler2, Lisia von Diemen4.   

Abstract

The COVID-19 pandemic has brought major challenges to healthcare systems and public health policies globally, as it requires novel treatment and prevention strategies to adapt for the impact of the pandemic. Individuals with substance user disorders (SUD) are at risk population for contamination due to multiple factors-attributable to their clinical, psychological and psychosocial conditions. Moreover, social and economic changes caused by the pandemic, along with the traditional difficulties regarding treatment access and adherence-will certainly worsen during this period, therefore aggravate their condition. In addition, this population are potential vectors of transmission. In that sense, specific strategies for prevention and treatment must be discussed. health care professionals dealing with SUD must be aware of the risks and challenges they will meet during and after the COVID-19 outbreak. Addiction care must be reinforced, instead of postponed, in order to avoid complications of both SUD and COVID-19 and to prevent the transmission of coronavirus.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 33242814     DOI: 10.1016/j.psychres.2020.113096

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  2 in total

Review 1.  COVID's Impact on Non-communicable Diseases: What We Do Not Know May Hurt Us.

Authors:  Karl Gordon Patti; Payal Kohli
Journal:  Curr Cardiol Rep       Date:  2022-05-07       Impact factor: 3.955

2.  A rise in cases of nitrous oxide abuse: neurological complications and biological findings.

Authors:  Maximilian Einsiedler; Paul Voulleminot; Stanislas Demuth; Pauline Kalaaji; Thomas Bogdan; Lucas Gauer; Cécile Reschwein; Aleksandra Nadaj-Pakleza; Jérôme de Sèze; Laurent Kremer; Ivana Schroder; Kévin Bigaut
Journal:  J Neurol       Date:  2021-07-10       Impact factor: 6.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.